Onterris, Inc. Income Taxes Disclosure
12. INCOME TAXES
The following is a geographical breakdown of income (loss) before the provision for income (loss) taxes as of December 31:
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Pre-tax income (loss): |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
$ |
17,189 |
|
|
$ |
(54,860 |
) |
|
$ |
(35,111 |
) |
Foreign |
|
|
(5,968 |
) |
|
|
542 |
|
|
|
3,272 |
|
Total |
|
$ |
11,221 |
|
|
$ |
(54,318 |
) |
|
$ |
(31,839 |
) |
Income tax expense (benefit) for the years ended December 31, is comprised of the following:
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Current: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
$ |
29 |
|
|
$ |
244 |
|
|
$ |
— |
|
State |
|
|
2,271 |
|
|
|
817 |
|
|
|
1,840 |
|
Foreign |
|
|
1,081 |
|
|
|
1,887 |
|
|
|
(1,131 |
) |
Total current tax expense |
|
|
3,381 |
|
|
|
2,948 |
|
|
|
709 |
|
Deferred: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
|
10,053 |
|
|
|
1,160 |
|
|
|
(438 |
) |
State |
|
|
(452 |
) |
|
|
1,850 |
|
|
|
(960 |
) |
Foreign |
|
|
(918 |
) |
|
|
2,038 |
|
|
|
(291 |
) |
Total deferred tax expense |
|
|
8,683 |
|
|
|
5,048 |
|
|
|
(1,689 |
) |
Total: |
|
|
|
|
|
|
|
|
|
|||
Federal |
|
|
10,082 |
|
|
|
1,404 |
|
|
|
(438 |
) |
State |
|
|
1,819 |
|
|
|
2,667 |
|
|
|
880 |
|
Foreign |
|
|
163 |
|
|
|
3,925 |
|
|
|
(1,422 |
) |
Income tax expense (benefit) |
|
$ |
12,064 |
|
|
$ |
7,996 |
|
|
$ |
(980 |
) |
The Company’s deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, and includes the impact of any valuation allowance on net deferred tax assets.
Significant components of the Company’s deferred tax assets and liabilities as of December 31, are as follows:
|
|
2025 |
|
|
2024 |
|
||
Deferred tax assets: |
|
|
|
|
|
|
||
Net operating losses |
|
$ |
11,000 |
|
|
$ |
14,021 |
|
Section 163(j) interest limitation |
|
|
3,058 |
|
|
|
7,627 |
|
Equity compensation |
|
|
2,063 |
|
|
|
7,669 |
|
Contingent consideration |
|
|
8,621 |
|
|
|
9,007 |
|
Lease liabilities |
|
|
17,182 |
|
|
|
(15,274 |
) |
Accrued compensation |
|
|
6,991 |
|
|
|
4,117 |
|
Transaction costs |
|
|
2,384 |
|
|
|
2,525 |
|
Section 174 research & experimental |
|
|
648 |
|
|
|
1,312 |
|
Interest rate swap |
|
|
106 |
|
|
|
(402 |
) |
Other |
|
|
8,067 |
|
|
|
6,593 |
|
Total deferred tax asset |
|
|
60,120 |
|
|
|
37,195 |
|
Deferred tax liabilities: |
|
|
|
|
|
|
||
Intangible assets |
|
|
(24,650 |
) |
|
|
(22,399 |
) |
Property and equipment |
|
|
(14,104 |
) |
|
|
(13,944 |
) |
ROU assets |
|
|
(18,027 |
) |
|
|
14,986 |
|
Other |
|
|
(90 |
) |
|
|
(1,529 |
) |
Total deferred tax liability |
|
|
(56,871 |
) |
|
|
(22,886 |
) |
Valuation allowance |
|
|
(25,066 |
) |
|
|
(27,621 |
) |
Net deferred tax liability |
|
$ |
(21,817 |
) |
|
$ |
(13,312 |
) |
The effective tax rate of the Company's provision (benefit) for income taxes differs from the federal statutory rate for the years ended December 31, are as follows:
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|
|||||||||||||||
US federal statutory tax rate |
|
$ |
2,356 |
|
|
|
21.00 |
|
% |
$ |
(11,408 |
) |
|
|
21.00 |
|
% |
$ |
(6,686 |
) |
|
|
21.00 |
|
% |
State and local income taxes, net of federal income tax effect(1) |
|
|
1,150 |
|
|
|
10.25 |
|
|
|
2,511 |
|
|
|
(4.62 |
) |
|
|
477 |
|
|
|
(1.50 |
) |
|
Effect of cross-border tax laws |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Global intangible low-taxed income |
|
|
316 |
|
|
|
2.81 |
|
|
|
1,410 |
|
|
|
(2.60 |
) |
|
|
1,067 |
|
|
|
(3.35 |
) |
|
US tax impact of foreign branches |
|
|
(174 |
) |
|
|
(1.55 |
) |
|
|
(501 |
) |
|
|
0.92 |
|
|
|
(148 |
) |
|
|
0.47 |
|
|
Sale of Denmark business |
|
|
566 |
|
|
|
5.05 |
|
|
|
— |
|
|
|
0.00 |
|
|
|
— |
|
|
|
0.00 |
|
|
Tax credits |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Federal research and development credit |
|
|
(1,139 |
) |
|
|
(10.15 |
) |
|
|
— |
|
|
|
0.00 |
|
|
|
— |
|
|
|
0.00 |
|
|
Change in valuation allowance |
|
|
157 |
|
|
|
1.40 |
|
|
|
(911 |
) |
|
|
1.68 |
|
|
|
(4,421 |
) |
|
|
13.88 |
|
|
Nondeductible items |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Equity compensation |
|
|
7,636 |
|
|
|
68.06 |
|
|
|
1,519 |
|
|
|
(2.80 |
) |
|
|
539 |
|
|
|
(1.69 |
) |
|
Mark to market - fair value derivative |
|
|
(4,247 |
) |
|
|
(37.85 |
) |
|
|
253 |
|
|
|
(0.47 |
) |
|
|
(1,410 |
) |
|
|
4.43 |
|
|
Meals |
|
|
365 |
|
|
|
3.25 |
|
|
|
365 |
|
|
|
(0.67 |
) |
|
|
526 |
|
|
|
(1.65 |
) |
|
Transaction expense - deemed contribution to controlled foreign corporation |
|
|
— |
|
|
|
0.00 |
|
|
|
318 |
|
|
|
(0.59 |
) |
|
|
492 |
|
|
|
(1.55 |
) |
|
Worldwide changes in unrecognized tax benefits |
|
|
624 |
|
|
|
5.56 |
|
|
|
— |
|
|
|
0.00 |
|
|
|
— |
|
|
|
0.00 |
|
|
Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Federal deferred tax adjustments |
|
|
1,346 |
|
|
|
12.00 |
|
|
|
10,659 |
|
|
|
(19.62 |
) |
|
|
9,606 |
|
|
|
(30.17 |
) |
|
Federal tax return true up |
|
|
222 |
|
|
|
1.98 |
|
|
|
(940 |
) |
|
|
1.73 |
|
|
|
448 |
|
|
|
(1.41 |
) |
|
Section 162(m) compensation deduction limitation |
|
|
1,229 |
|
|
|
10.95 |
|
|
|
183 |
|
|
|
(0.34 |
) |
|
|
22 |
|
|
|
(0.07 |
) |
|
Other |
|
|
239 |
|
|
|
2.13 |
|
|
|
725 |
|
|
|
(1.34 |
) |
|
|
539 |
|
|
|
(1.69 |
) |
|
Foreign tax effects |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Canada |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Rate differential |
|
|
(203 |
) |
|
|
(1.81 |
) |
|
|
18 |
|
|
|
(0.03 |
) |
|
|
153 |
|
|
|
(0.48 |
) |
|
Return-to-provision adjustments |
|
|
756 |
|
|
|
6.74 |
|
|
|
2,953 |
|
|
|
(5.44 |
) |
|
|
(466 |
) |
|
|
1.46 |
|
|
Impact of scientific research and experimental development credits |
|
|
(641 |
) |
|
|
(5.72 |
) |
|
|
269 |
|
|
|
(0.50 |
) |
|
|
(2,028 |
) |
|
|
6.37 |
|
|
Other |
|
|
67 |
|
|
|
0.60 |
|
|
|
(101 |
) |
|
|
0.19 |
|
|
|
11 |
|
|
|
(0.04 |
) |
|
Australia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Rate differential |
|
|
999 |
|
|
|
8.90 |
|
|
|
172 |
|
|
|
(0.32 |
) |
|
|
46 |
|
|
|
(0.14 |
) |
|
Change in valuation allowance |
|
|
— |
|
|
|
0.00 |
|
|
|
— |
|
|
|
0.00 |
|
|
|
(153 |
) |
|
|
0.48 |
|
|
Other foreign jurisdictions |
|
|
440 |
|
|
|
3.91 |
|
|
|
502 |
|
|
|
(0.63 |
) |
|
|
406 |
|
|
|
(1.02 |
) |
|
Total |
|
$ |
12,064 |
|
|
|
107.51 |
|
% |
$ |
7,996 |
|
|
|
(14.45 |
) |
% |
$ |
(980 |
) |
|
|
3.33 |
|
% |
(1) In each year, the state and local income taxes which comprise the majority of the state and local income taxes, net of federal effect category are California and Pennsylvania.
The cash paid for income taxes (net of refunds) during the year was as follows:
|
|
Year Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Federal |
|
$ |
540 |
|
|
$ |
— |
|
|
$ |
— |
|
State and local |
|
|
|
|
|
|
|
|
|
|||
Pennsylvania |
|
|
213 |
|
|
|
307 |
|
|
|
614 |
|
Texas |
|
|
200 |
|
|
|
219 |
|
|
|
(129 |
) |
Alabama |
|
|
613 |
|
|
|
89 |
|
|
|
9 |
|
California |
|
|
1,045 |
|
|
|
87 |
|
|
|
10 |
|
Other |
|
|
1,200 |
|
|
|
1,572 |
|
|
|
493 |
|
Total state and local |
|
|
3,271 |
|
|
|
2,274 |
|
|
|
997 |
|
Foreign |
|
|
|
|
|
|
|
|
|
|||
Canada |
|
|
195 |
|
|
|
1,232 |
|
|
|
— |
|
Australia |
|
|
1,499 |
|
|
|
688 |
|
|
|
— |
|
Total foreign |
|
|
1,694 |
|
|
|
1,920 |
|
|
|
— |
|
Total |
|
$ |
5,505 |
|
|
$ |
4,194 |
|
|
$ |
997 |
|
The Company elected to account for the global intangible low-taxed income inclusion as a period cost.
The Company recorded a valuation allowance against its U.S., Germany, Belgium, Sweden, and Denmark net deferred tax assets as realization of such assets is not more likely than not. The impact of indefinite lived deferred items was considered in recording such valuation allowance. The decrease in the Company’s valuation allowance was $2.6 million during the year ended December 31, 2025. The increase in the Company's valuation allowance was $3.5 million during the year ended December 31, 2024.
As of December 31, 2025, US federal and state net operating loss carryforwards of approximately $31.9 million and $94.2 million are available to offset future federal and state taxable income, respectively.
Federal net operating loss carryforwards carry forward indefinitely while the Company’s state net operating loss carryforwards will begin to expire during various years, dependent on the jurisdiction.
Additionally, as of December 31, 2025, the Company has federal and state research and development credit carryforwards of $0.8 million and $0.1 million, respectively. The federal and state credits will begin to expire in 2044, unless previously utilized.
The Company records uncertain tax positions in accordance with ASC 740, on the basis of a two-step process in which (i) the Company determines whether it is more likely than not a tax position will be sustained on the basis of the technical merits of such position and (ii) for those tax positions meeting the more-likely-than-not recognition threshold, the Company would recognize the largest amount of tax benefit that is more than 50.0% likely to be realized upon ultimate settlement with the related tax authority. The following table summarizes the gross amount of the Company’s uncertain tax positions:
|
|
2025 |
|
|
Balance at beginning of the year |
|
$ |
— |
|
Increases related to prior year tax positions |
|
|
334 |
|
Decreases related to prior year tax positions |
|
|
— |
|
Increases related to current year tax positions |
|
|
289 |
|
Decreases related to lapse of statute of limitations |
|
|
— |
|
Balance at end of the year |
|
$ |
623 |
|
Included in the balance of uncertain tax positions as of December 31, 2025, is $0.6 million that would affect the effective tax rate, if reversed, subject to changes in the Company’s valuation allowance.
The Company’s policy is to recognize interest and penalties related to income tax matters as a component of income tax expense. As of December 31, 2025, no interest and penalties have been recognized.
The Company is subject to audit by federal and state tax authorities in the ordinary course of business. The Company’s federal income tax returns remain subject to examination generally for the taxable year through the current taxable year, except for certain prior taxable years with net operating loss carry forwards that will remain subject to examination until the expiration of the statute of limitations for the taxable years of utilization of such net operating losses. The Company files tax returns in multiple US state jurisdictions which remain subject to examination for various years depending on such state jurisdiction. The Company is also subject to audit by tax authorities in Canada, Australia, Germany, Sweden, Belgium, and Denmark for which returns are subject to examination for various years, dependent on the jurisdiction.
The Organization for Economic Co-operation and Development (“OECD”) has introduced a framework to implement a global minimum corporate tax of 15%, referred to as Pillar Two. Many aspects of Pillar Two are effective beginning in calendar year 2024 and other aspects will be effective beginning in calendar year 2025. While it is uncertain whether the U.S. will adopt Pillar Two, certain countries in which the Company operates have adopted legislation and other countries are in the process of introducing legislation to implement Pillar Two. While the Company does not expect Pillar Two to have a material impact on its effective tax rate, the Company's analysis is ongoing as the OECD releases additional guidance and countries implement additional legislation.
The One Big Beautiful Bill Act ("OBBB Act") was enacted on July 4, 2025, in the United States. The OBBB Act includes several significant provisions, including re-establishing a 100% bonus depreciation deduction, re-establishing rules in calculating business interest expense limitations pursuant to Internal Revenue Code §163(j), changing the calculation of international tax inclusions, and removing the capitalization requirements for domestic research or experimental (R&E) expenditures paid or incurred in tax years beginning after December 31, 2024. Management has considered applicable tax impacts of the OBBB Act within the 2025 financial statements.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Mar 24, 2021 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.